Engineered cells for allograft

CN121127579APending Publication Date: 2025-12-12SHANGHAI BEIHENG BIOTECHNOLOGY CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380096057.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-03-20
Publication Date
2025-12-12

Smart Images

  • Figure CN121127579A_ABST
    Figure CN121127579A_ABST
Patent Text Reader

Abstract

In some embodiments, engineered cells are provided for use in allograft, the engineered cells having an HLA-C1 / C2 typing. Also provided are pharmaceutical compositions comprising the engineered cells, as well as methods of reducing transplant rejection and treating or preventing cancer, infection or autoimmune disease.
Need to check novelty before this filing date? Find Prior Art